Rigel Pharmaceuticals's chart data is dated 2026-10-08. Recorded technical signals: MA aligned. There are 8 published signal records.
Rigel Pharmaceuticals last closed at $48.72 (+1.52%) on 2026-10-08. Signals today: MA aligned. Listed on Nasdaq. Trailing 12 months PER is 3.0×. Its overall grade ranks 324 of 738 stocks in Healthcare.
About this company
Rigel Pharmaceuticals last closed at $48.72 (+1.52%) on 2026-10-08. Signals today: MA aligned. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B · 324/738
Valuation grade D
Related stocks
- RocheCompetitor
면역·혈액질환 치료제에서 경쟁하는 글로벌 제약사
- NovartisCompetitor
혈액질환·면역질환 영역의 대형 경쟁 제약사
- AmgenCompetitor
혈액질환 및 염증성 질환 치료제 시장에서 경쟁
ETFs holding this stock
Virtus LifeSci Biotech Products ETF · First Trust Dow Jones Select MicroCap Index Fund · First Trust Active Factor Small Cap ETF
Details →About Rigel Pharmaceuticals
- What technical signals does Rigel Pharmaceuticals (RIGL) have?
- Rigel Pharmaceuticals current technical signals: MA alignment (score 0.78).
- Is Rigel Pharmaceuticals a cup-and-handle pattern?
- No. Rigel Pharmaceuticals has no valid Cup signal right now.
- What published figures are available for Rigel Pharmaceuticals?
- Market cap: $884.33M. Trailing 12 months PER: 3.0×. Latest quarter PBR: 2.24×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about Rigel Pharmaceuticals, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.